Although our MR framework supports causal inference, the precise biological mechanism underlying observed immune–cytokine–cancer interactions (e.g., BAFF-R/MIF crosstalk) requires experimental validation using preclinical models. This evidence concerns the gene TNFRSF13C and cancer.